Theranostics Health to Present at 8th Annual Mid-Atlantic BIO Conference

Gaithersburg, MD, August 17, 2012. Theranostics Health, Inc., a privately-held biotechnology company seeking to develop proteomic-based personalized medicine technologies, announced today that Dr. Glenn Hoke (President and Chief Executive Office) will be presenting at the Emerging Growth track at the 2012 Mid-Atlantic BIO Conference in Bethesda, MD. Dr. Hoke will be providing an overview to potential investors into Theranostics Health’s scientific and business development efforts to commercialize Theranostics’ TheraLink™ Assays for use in patients with malignant diseases.

Mid-Atlantic BIO Investor Presentations